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Abstract: Professional development activity is needed to ensure practitioners are up to date and pro-
viding optimal patient care. This includes, but is not restricted to, mandatory continuing professional
development (CPD) or continuing education (CE) requirements, which differ by professions globally
and within countries. This study aimed to investigate perceptions, participation, and individual
practice for healthcare professionals in Great Britain (GB) and pharmacists globally to identify simi-
larities and differences after the introduction of revalidation for pharmacists in GB. Qualitative data
was received through interviews, which was analysed using content analysis. In total, 24 interviews
were completed with pharmacists registered globally, and healthcare professionals registered in GB.
A culture of CPD was seen for healthcare professionals in GB and globally for pharmacists; there
was no consistent model. Face-to-face activity was common, with an increase in online provision,
especially where large geographies were seen. Most learning was completed in the professional’s
own time. Multiple providers were seen, with the evaluation of events using questionnaires being
commonplace. Different formats of learning were useful for different topics, with skills learning being
better when face-to-face. Although varied requirements were in place, regulation should support
patient-based practice outcomes. This study showed that commitment to learning was similar in
different professions in GB and by pharmacists globally, with similar benefits and challenges.
Keywords: pharmacist; healthcare professional; professional development; CPD; CE; global
1. Introduction
Professional development activity is needed to ensure practitioners are up to date with
current drugs and guidelines, as well as to ensure that they are providing optimal patient
care. Continuing Professional Development (CPD) is a lifetime commitment of providing
care in a safe and effective way [1]. Continuing Education (CE), or CPD as professional
development activities are commonplace for healthcare professionals globally, although the
mandatory requirements in place are currently varied. Professional development activity
is essential for pharmacists to ensure their knowledge and competence is maintained
throughout their career; however, learning is not restricted to only mandatory requirements,
as it is also self-driven. Whilst CE has a primary focus on pure participation in activity and
recording of the hours of activity completed, CPD demonstrates reflection on learning needs,
planning, participation, and evaluation. It has been noted that CPD offers a greater return
of investment compared to CE, as there is a greater focus on context and application [2,3].
It has been noted that CPD must facilitate changes in behaviour to support advancement of
pharmacy practice [4].
For pharmacists, multiple reports have reviewed the requirements set up at a global
level for mandatory professional development activity [1,5–8] and these show a wide
range of variation amongst countries. In the International Pharmaceutical Federation (FIP)
global report on CE/CPD in 2014, it was seen that 33 out of 66 surveyed countries had no
requirements in place for pharmacists. Where a mandatory requirement to demonstrate
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CE or CPD is seen, the requirements are wide and varied across and within countries.
Current requirements may be linked to the length of time that the profession has been
established, the role of the pharmacist, or current regulation requirements [5]. Driesen
et al. [9] noted that there is no global model in place for professional development activities
of pharmacists.
From looking at the international pharmacist CPD reports available [1,5,6], mandatory
CPD systems are in place in Australia, Canada, Great Britain (GB), Ireland, Malaysia,
Namibia, New Zealand, Northern Ireland, Oman, Portugal, Singapore, and the United
Arab Emirates (UAE). It is noted that pharmacy in Portugal and the UAE is regulated by
Government/Ministry, and these have CPD credit systems, akin to CE due to hours of
training that has been completed being recorded, whereas all other listed countries have
mandatory CPD for pharmacists that is regulated by councils or boards at the individual
state level in a country, requiring reflection of practice. The United States of America
(USA) is the only country listed in the reports, which looked at data until 2014, as having a
mandatory CE system, in some states. Since 2014, CPD is now much more commonplace in
the USA [10].
Models or formats used for CE/CPD differ both globally and within countries, with
differences seen for models and preferences for learning [11]. Currently providers of
professional development activity have no global reference for requirements [12] due
to differing models and expectations. Where there are no CE/CPD requirements in a
country, pharmacists may still want to engage in learning activities, so identifying current
approaches used may benefit those introducing models in the future. In GB, as in countries
globally, healthcare professions are registered by regulatory bodies, along with the majority
having professional bodies to support them. Nurses and doctors are the first and second
largest healthcare professions in GB, with pharmacists being the third largest and dentists
being the fourth largest healthcare profession [13]. The Nursing and Midwifery Council
(NMC) is the regulator for nurses and midwifes [14]. The Royal College of Nursing (RCN) is
the professional body for nurses. The General Medical Council (GMC) regulates the medical
profession. The British Medical Association (BMA) is the trade union and professional body
for medics, providing events and learning materials, including access to the British Medical
Journal (BMJ) and BMJ learning, an online learning platform. The regulator for pharmacy
in GB is the General Pharmaceutical Council (GPhC). All GPhC registrants have access to
learning by the Centre for Pharmacy Postgraduate Education (CPPE). The professional body
for pharmacists is the Royal Pharmaceutical Society (RPS). The General Dental council
(GDC) regulate dentists, and the health and care professions council (HCPC) regulate
16 professions working in health, psychological, and social work professions including
radiographers, paramedics, physiotherapists, and occupational therapists [15]. Health
Education England (HEE) provides an overview of workforce planning and provides
education to those in health professions [16].
In 2014, Tran et al. [1] published information about CPD requirements in various
countries, comparing that of dentists, nurses, pharmacists, and physicians. Tran’s study
used data for GB that had been gathered in 2013 through a literature review. Since the
review by Tran in 2013, [1] two professions in GB have seen changes in the regulatory
requirements of CPD; pharmacists and dentists. In 2018, revalidation was introduced
for pharmacists in GB, incorporating CPD, which updated regulatory requirements for
re-registration. Revalidation is in place to support public confidence in professionals [17,18].
Prior to the introduction of revalidation for pharmacists, there was a requirement for nine
CPD cycles to be completed annually. With revalidation, this has been amended to be
four CPD cycles, but also to complete a reflective account and carry out a peer discussion.
For dentists, as of 1 January 2018, there is an enhanced CPD process [19] replacing the
old process, which has been in place since 2008, and all dentists will transition to the new
scheme at the end of their five-year CPD cycle.
As with CPD requirements, revalidation requirements are set by each professional
regulator. Whilst both professions with updated requirements have seen a reduction in
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overall requirements, there is more emphasis on verified learning and showing the impact
of learning on practice. A review of CPD requirements of UK health professionals published
in 2020 acknowledged that the regulatory requirements are the minimum expectation and
professional development activity is likely to exceed that set by the regulator [20].
Whilst previous studies have looked at requirements and comparisons of CPD/CE
globally for pharmacists, or compared requirements for GB based healthcare professionals,
no qualitative studies can be found. This is the first in-depth qualitative analysis, including
interviews from practising professionals, and representatives of professional groups, focus-
ing on experiences of professional development activity for healthcare professionals in GB
and pharmacists globally. As GB based pharmacists have amended CPD and revalidation
requirements in place, a comparison of other healthcare professionals in GB, plus global
pharmacists, allows an understanding of how GB pharmacists requirements compare in
terms of local healthcare colleagues, but also global pharmacy colleagues. With increased
emphasis on a multi-professional approach to patient care being seen, perceptions from
learning providers and professional bodies will also support understanding of alignment
in practice, to identify any learnings that can be shared across professions, both in GB and
globally.
The aim of this study was to investigate perceptions, participation, and individual
practice for regulatory professional development activity requirements of healthcare pro-
fessionals and healthcare regulators or support bodies in GB and pharmacists globally, in
terms of provision, uptake, and attitudes, in order to identify similarities and differences
after the introduction of revalidation for pharmacists in GB.
2. Materials and Methods
2.1. Study Design
Qualitative data from healthcare professionals in GB plus pharmacists globally was
received using semi-structured, one-on-one interviews. This approach was taken to gain
perceptions on how regulations or practice can affect individual practices. An interview
proforma consisting of 13 questions was designed. It aimed to understand current provision,
support, participation, and evaluation of professional development education and training
activities. In addition, it captured thoughts about the best options and attitudes towards
preferences for delivery of learning events, to compare and contrast current practice and
views. The interview schedule received face validation for content from three pharmacists
and a nurse in GB not involved in the study. A copy of the interview schedule can be found
in Appendix A. To ensure study integrity in the design and analysis, the COREQ checklist
was used. This can be found in Appendix B.
2.2. Participants: Sampling and Recruitment
Human participants were involved in data collection through semi-structured inter-
views, completed either face-to-face or via telephone, when face-to-face was not possible.
The lead author completed all the interviews.
Potential participants were contacted by email and purposive convenience sampling
was used through local contacts to gain participants. Contacts in pharmacy, nursing,
medicine, and dentistry from previous committee work were emailed to gain an under-
standing of requirements and experiences for colleagues in other pharmacists in GB. Only
one individual from each profession, country, or organisation was targeted to gain a
perspective of how individual practice is interpreted, noting that perceptions would be
self-reported. Pharmacists from countries including Great Britain as the home country,
as well as Ireland, Australia, Belgium, Canada, Malta, the USA, and New Zealand were
approached as colleagues who had an interest in professional development activity, due to
previous conference attendance. Colleagues registered in other countries, along with those
registered on the Overseas Pharmacists’ Assessment Programme (OSPAP) course in GB
were also approached. OSPAP is a course for pharmacists from outside of the European
Union who wish to join the register in GB. Practising pharmacists were chosen for the
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interview to understand the reality of how requirements set by regulators are applied in
practice. Participants, when contacted, were made aware of the study contributing towards
the lead researcher’s PhD and were made aware of her previous research and practice as a
pharmacist.
2.3. Data Collection
Individuals who agreed to participate in an interview were emailed an information
sheet, outlining the study aims and objectives, as well as the background of the researchers,
including the right to withdraw from the study and a consent form, which they were asked
to read, sign, and return prior to the agreed interview time if not available face-to-face.
Those who were being interviewed face-to-face were given a copy of the information
sheet and consent form prior to the interview commencing. Where face-to-face interviews
occurred, the researcher travelled to a convenient workplace location for the participant. All
other interviews occurred over the telephone. Verbal or written consent was obtained for
recording, as appropriate. Interviews lasted between 10 to 15 min. All interviews were voice
recorded and transcribed verbatim prior to deletion. No other notes were made during the
interviews. The interviews took place between February 2017 and October 2018. All those
who initially agreed to be interviewed completed an interview, in order that all views and
experiences were recorded, and to ensure representation of countries and professions in GB.
One female member of the research team (RM) who was completing her PhD at the time of
the study and had three years prior experience of qualitative research completed all the
interviews and completed the transcriptions. No other individuals besides the researcher
and participant were present during all interviews.
2.4. Data Analysis
Inductive content analysis was used to combine data gathered through interview
to give a general statement. Working with qualitative data, content analysis allows the
integrity of the narrative to be maintained, using a summary along with supporting
excerpts [21]. The questions were used as codes to gain responses for comparison across
professions and countries. Frequency counts were used as a form of content analysis to
highlight the most common topics or words given during answers [22]. This was completed
by one member of the research team (RM) with the other member (RK) reviewing all
transcripts to ensure the accuracy of findings. Analysis was completed manually. As
the aim of the study was to identify perceptions in approach about current practice, the
directed content analysis approach allowed for validation of current knowledge and could
determine relationships between codes. Transcripts were read to ensure there were no
transcription errors, and then read again to enable immersion. Quotes were used to
highlight any key messages highlighted from the coding.
3. Results
Interviews took place with one representative from each of the following healthcare
practitioners in GB (n = 5): dentist, hospital doctor, nurse, paramedic, and radiographer.
Interviews took place with one member of personnel from the following support/training
bodies in GB (n = 5): BMA, BMJ learning, CPPE, HEE, and RPS. There were 14 pharmacists
interviewed who practiced in different countries. One pharmacist was registered in each of
Australia, Belgium, Chile, GB, India, Iraq, Ireland, Malaysia, Malta, Pakistan, Philippines,
and USA that was interviewed. In addition, two pharmacists from New Zealand were
interviewed. Despite multiple emails, no representative from South Africa or Canada
was recruited. Where quotes are used in the text, the role of the GB based healthcare
professional, or the country of the global pharmacist, are given. As a GB pharmacist was
interviewed, this can be used as a comparison for both professions in GB and pharmacists
globally. There is a mixture of CPD and CE requirements around the world, along with
countries who do not have any regulatory requirements. Interview findings have been
summarised in Tables 1 and 2.
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Table 1. Summary of requirements for CPD/CE for surveyed professions in GB from interviews.




Place, if Planned Sessions Providers
Tools to Support
Application of Learning Evaluation of Events

















Case study approach to
learning None
Doctor CPD Portfolio. Demonstrationof competencies Mainly during the day Deaneries
Online modules.
Handouts Differs by provider
Radiographer CPD Mixture of anything Weekends or lunchtime Royal college





Paramedic CPD Attendance at courses Evenings and during theday
Hospital Trust




Attendance at courses in
London
2 h in the evening twice






(BMJ) learning (Provider) Online courses
Anytime as online. Hour







Society (Professional body) No role in provision
No answer provided as no
role in provision
No answer provided as
no role in provision
No answer provided as










conferences during the day
or at weekends. Lunchtimes














Pharmacy 2022, 10, 7 6 of 19
Table 2. Summary of requirements for CPD/CE for pharmacists from surveyed countries.
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Table 2. Cont.
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3.1. Professional Development Activity Practices
In GB, a culture of CPD is seen with all professions that were interviewed engaging in
CPD (n = 5/5), echoing GB pharmacists. Of these, hours of CPD are specified for nurses
and dentists, with the HCPC having a portfolio approach to learning. For pharmacists,
the number of cycles that need to be completed is specified. For doctors, nurses and
pharmacists, CPD requirements are undertaken as part of mandatory revalidation activity.
Of the 14 pharmacists that were interviewed, 7 were from countries where they needed to
undertake CPD: Australia, GB, Iraq, Ireland, Malaysia, and New Zealand (2 pharmacists);
3 pharmacists had to undertake CE: Belgium, Philippines, and the USA; and the remainder
had no requirement. Of the nine who engaged in CPD/CE, six of these were a points-based
or credit-based system (Australia, Belgium, Malaysia, Philippines, New Zealand, and the
USA). Hours of CPD (Australia, New Zealand) or CE (Belgium) were also required in some
cases to gain credits along with a specification of the number of CPD cycles to complete (GB).
It must be noted that the interview responses represent individual practising pharmacists
and the requirement on their practice, e.g., in the USA the pharmacist interviewed had
a CE requirement, whereas other pharmacists from other states may be subject to CPD
requirements.
3.2. How Is Learning Achieved and Verification of Learning
Most professions in GB could achieve their learning through multiple formats. The
paramedic in GB was the only professional who stated learning is mainly through atten-
dance, as seen in the quote below.
‘A lot of it is attendance at courses and sort of higher education things then you have to
write up how it applies to what you are going to do.’ Paramedic.
All other professions noted a mixture of available activities, with opportunity to
undertake face-to-face or alternative methods of learning. Providers spoke about their
online training provision (BMJ learning) or portfolio of learning options (BMA, CPPE).
Face-to-face learning activity was the most common seen from the interviews, although in
Western countries, there was an increase of online courses available, with online provision
noted in 7 out of 13 countries for pharmacists (Australia, Belgium, GB, Ireland, Malaysia,
New Zealand, and the USA,) allowing for flexibility of learning. Where online learning was
mentioned, this was always in conjunction with a face-to-face offering. Face-to-face activity
comprised multiple activities, including conferences, postgraduate programmes, or courses.
The opportunity to not just undertake face-to-face, but also participate in alternative options
was noted as positive:
‘We have a lot of formats available. We have online learning, so we have a number of
e-learning courses . . . Face-to-face workshops.’ CPPE.
Gaining the credits can be complex to understand, with Australia, Belgium, and New
Zealand having scaling systems in place. The groups of activity seen in Australia and New
Zealand are similar. The quote below outlines the requirements in New Zealand:
‘Every year you have to record your CPD and it is done online. And you have to get
20 points a year minimum, but over 3 years you have to get 90 points. And then they
split it up and you need a certain number of group one points, a certain number of group
two points and a certain number of group three points. Now, group one points–that just
means like, reading an article or, reading a paper or something like that, so you can show
you have done something. In group two though, you have to do learning, but also be
assessed on it, so there will be, if you go to a conference and they give you a test at the end
and you pass it, you can put that down. And then group three you need a learning partner
and you have to do, it is a combination of doing all of your group one and group two. So
you are learning and then showing how you are using that in practice. So an example
could be like, um, one of the group three points ones I did was writing a community
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acquired pneumonia guidelines. You do the research then you write the guideline, then
you put it in practice and you see how practice is changing as a result.’ New Zealand 2.
Ireland has a separate organisation in place to implement a CPD system, and supports
pharmacists to achieve requirements, and they also commission education and training
programmes. This is outlined in the quote below:
‘So every year, a pharmacist needs to apply for continued registration and then they
also need to engage with the Institute of Pharmacy (IIOP) . . . they need to maintain an
e-portfolio on the IIOP website . . . They need to demonstrate they are engaging in CPD
. . . we must be able to have a direct evaluation of a pharmacists’ knowledge, skills, and
competencies in a range of patient facing roles . . . we have copied the Ontario model, so a
pharmacist will come to a central location. It is run twice a year, on Saturday and Sunday
each weekend, and they go through eight what we call standardised patient interactions
. . . then they move to a clinical knowledge review, which is an online e-assessment and
they sit at the computer with, I think, 16 cases, each has 3 multiple choice questions on
each, it is open book, and they need to complete that in just under 2 h . . . ’ Ireland.
Interestingly, although no formal requirement exists in many countries, courses are
still offered, often with high participation rates, as seen in Malta, as an example below.
‘There are no legal requirements but there are continuing education courses routinely. I
would say with a very high participation of over 60%, 70% of pharmacists, even though
it is voluntary.’ Malta.
Certification or proof of attendance/participation is commonplace to fulfil CPD re-
quirements. Certificates are required for three professions (nurses, doctors, and dentists)
for verifiable CPD. These are required for submission to the regulator for audit or for
use during an appraisal for doctors. However, all professions stated that the regulator
only looks at a small sample of records submitted. Of the countries engaging in CPD/CE,
certification or proof of attendance/participation is commonplace in all but Iraq. Even
where CPD/CE is not a requirement, it is seen that certificates are issued at times, such as
in India.
3.3. How and When Learning Takes Place
A large culture of carrying out learning in the professional’s own time is seen both
in GB and globally. All professions in GB stated that some learning should be completed
independently (n = 6/6). Doctors are seen to be given protected time during work hours,
and dependent on the hospital trust, nurses may be given this too. Protected time for
pharmacists is seen in hospitals in New Zealand and the USA, but not in the community
sector. Australia and Belgium do show that some money could be claimed back from
attendance. Evenings are a very common time for activity to take place (dentist, BMA,
CPPE). Some activity predominantly occurs during the day (doctor) or mainly in the
evenings (dentists), with other professions having flexibility of events during the day or
the evening (nurses, paramedics, pharmacist). Radiographers noted weekend events being
common. The flexibility of offering learning events both during the day, evenings, and
weekends is widely seen globally for pharmacists. Where distance learning is offered, this
can be always accessed. Geography does play a part in the time of activity, as travelling
time to locations and the associated cost can affect attendance numbers, as seen in the quote
below.
‘And making the time to go after work is very difficult, and travelling, you don’t know if
it is local to you. And cost of travelling can be a bit much.’ Dentist.
Small countries, such as Malta, do not face problems with attendance. In the USA,
there are more daytime learning activities held, as well as in Iraq due to political reasons as
seen in the quote below.
‘During the day and sometimes the weekend . . . because of the situation it has moved
away from night and into more of the daytime.’ Iraq.
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3.4. Providers of Professional Development Activity
Professional bodies are the predominant providers of training across the board, al-
though employers, universities, and pharmaceutical companies also provide learning
opportunities. Globally for pharmacists, there are a few country-wide specific providers
e.g., Instituut voor Permanente Sudie voor Apothekers (IPSA), translated as the Institute for
Continuing Education for Pharmacists, for Flemish speakers and Brussels based pharma-
cists, along with Société Scientifique des Pharmacies Francophones (SSPF) for French speaking
pharmacists, in Belgium, CPPE in GB. Countries including Ireland and USA have accredit-
ing organisations to support commissioning and accreditation of training for pharmacists,
with Ireland using the Irish Institute of Pharmacy (IIOP) and USA having the accreditation
council for pharmacy education (ACPE). The ACPE accredits provider organisations.
3.5. Follow-Up after Events
A variety of support material is seen to support the application of learning into
practice. These include case studies being used during the session (nurse, dentist, CPPE,
Chile, Malta), vignettes (nurse), online material (CPPE, doctors, New Zealand), handouts
(doctors, pharmacists in GB, Iraq, USA), CPD support tools providing reflection points from
the session (pharmacist, radiographer, Ireland), and post course assessments (CPPE, New
Zealand, Australia, Belgium). Support targeted depending on the content of the session
was mentioned, as seen in the quote below:
‘Well, they will be your sort of conventional resources which are your written material
. . . You could have a memory stick with information on it, you could have access to online
material with a special code you could have. You could have leaflets, pamphlets, and
material. It is a combination. You could sometimes have access to MCQ questions and
interviews online, all sorts of things like that. It is targeted.’ New Zealand 1.
The BMA send out a list of the top information to remember after the event with
links to further learning. In some cases, it was stated that no support is given (paramedic).
Pharmacists in Belgium send out a list of the top information to remember after the event
with links to further learning. In some cases, it was stated that no support is given (India,
Philippines). When asked about any tools that are not currently utilised that may be of
benefit, review, and evaluation of learning, critical analysis/appraisal and handouts were
mentioned.
Evaluation of events takes place in numerous ways including online follow-up survey
(nurse, BMA, Ireland, USA), self-reflection (radiographer), and the most common, eval-
uation form (paramedic, pharmacist, CPPE, Australia, Belgium, pharmacist in GB, Iraq,
Malta, New Zealand, Philippines). It is noted, however, that this may not be seen as true
evaluation, as seen below:
‘We have feedback forms that everybody does. But that’s probably not true evaluation
because if you were going to do proper evaluation you are looking at what difference has
that made to one’s practice which you can’t measure in a two-hour workshop. So, at the
end of a two-hour workshop you can only measure at best I think, people’s intentions.’
CPPE.
Providers such as BMJ learning and HEE look at completion rates or turnover, as in
the quote below:
‘When it comes to courses, we commission and continue to do, we have contract with
evaluation points throughout the year that looks at turnover, student feedback, attainment
in previous years, and we have an annual quality setting process with providers.’ HEE.
A few stated that no evaluation takes place of the learning events (dentist, Malaysia,
Pakistan). When describing the content of the evaluation forms, it is seen that similar
questions are asked, covering what went well and what could be completed differently,
and in a few cases the intention of how the learning would be applied.
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3.6. Opinions on the Best Model for Professional Development Activity
A combination of face-to-face and online was seen to be a good approach, with
individuals having individual preferences according to age, learning style, work pattern,
or experience:
‘I think you will find most people do well with a balance, um, and also depends on
individuals learning style and what they like best.’ BMA.
‘I think both are really valuable. I think online is more accessible if you work shifts.’
Paramedic.
‘We do have the very traditional GPs where people want to read and do tests for an hour,
and then we have the much younger group that have completely different ways to learn,
and they just want to watch a video or something, so we are moving in that direction....’
BMJ learning.
‘A lot of people don’t have much flexibility due to hours of work and what they do, so
as much as they might want to go along to an evening meeting, where others might feel
supported there, they might need to be in their pharmacy stores till late, by which time
there is no enthusiasm to go on and do the things that are seen to be less of a requirement,
so something a bit more passive might be okay.’ Pharmacist GB.
Different formats suit different topics, such as skill development needing face-to-face
interventions, whereas knowledge updates are suitable to be completed online. This was
noted more than once, as seen below:
‘So, where you are looking for skill development you need to have face-to-face if you are
going to assess whether the objectives have been achieved . . . For others we rely more on
online, so, for example, do you need to have face-to-face training for an update on what
the changes in flu vaccine are every year, no....’ Ireland.
‘I think it depends on the topic you are covering, so, there are some things like, say
you want to get emergency hormonal contraceptive pill accredited, the online course is
sufficient, followed by, you know, a test at the end. When you want to discuss more
emerging themes and stuff like that then I think face-to-face is significant to make those
connections and it is more improvement-based initiatives. New Zealand 2.
Face-to-face delivery is seen to offer the advantage of being able to share ideas, net-
work, and have hands on experience. Geography and the time of event, along with time
needed to attend, were seen as barriers for face-to-face attendance.
‘I think face-to-face will always have that human element to it, and you will have an
opportunity to interact with peers, and learn with them.’ New Zealand 1.
‘Distance is a barrier in Australia . . . because they have, like, rural locations, so they are
quite adept to skype and teleconference and running things so you do things remotely
. . . It is a massive place, so to run national and things like that it is often online,
teleconference.’ Australia.
Online learning was a good opportunity for those who work shifts or those who
found time to be an issue, as it can be completed in an individual’s own time and online
overcomes geographical issues. Younger learners may also prefer this method:
‘Online is so good because you can just do it when you want. Some of it you can start it
and then pause it and go back to it.’ Dentist.
The cons of online learning were that it is seen as a ‘tick-box’ exercise and not taken as
seriously, with learners just being able to click through the material:
‘Face-to-face is the best, as e-learning, it does not, it is something that is not quite popular
as people don’t take it as seriously as such, they just think it is something they can do in
their own time, and they are mentally absent during those sessions as well.’ Pakistan.
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As seen above, it was noted that there should not be a ‘one size fits all’ approach as
individuals have different preferences.
4. Discussion
It is seen that, although all healthcare professions surveyed in GB are required to
undertake CPD, how this is completed varies. Three professions; medicine, nursing,
and pharmacy outline revalidation requirements that include CPD. Both pharmacists
and dentists have seen changes in requirements in recent years. As echoed in previous
international studies [1,5,6], most countries, as represented by the interviewees (9 out of 13),
had mandatory CPD/CE requirements for pharmacists in place. Even in those countries
where professional development activity requirements were not specified for pharmacists, a
culture of wanting to learn and stay up to date was seen. Whilst, for pharmacists in GB, CPD
is part of revalidation in line with doctors and nurses, giving assurance of joint emphasis
on patient outcomes, revalidation was not mentioned by any of the other pharmacists in
the sample population in this study.
This study shows that most CPD is completed in the professional’s own time, and
this could mainly be guided by personal learning needs, as for pharmacists in GB. When
looking at the literature, Pool et al. [23] in 2016 saw that for nurses, mandatory courses were
useful for complying with requirements, conferences were used for deepening knowledge,
and postgraduate education was used to develop careers. Although mandatory to complete
CPD for all professions, this study showed that only a few records are checked by the
regulators annually. This may impact on the importance professionals place on the entry.
When surveyed in 2009 [24], it was seen that 70.5% of nurses had participated in CPD in the
past year. In a systematic review of CPD attitudes of pharmacists in GB [2] it was identified
that overall, pharmacists understood the benefits of CPD participation; however, there was
no overall acceptance and uptake of CPD. In a study carried out by Thompson et al. in
2013 [25], 3 years after mandatory CPD was introduced in Australia, 91% of respondents
believed they knew the CPD requirements for renewal of registration. However, registrants
could not understand the difference between CPD and CE, with 76% believing they were
synonymous. They believed that more guidance on the frameworks available was needed.
This study identified the main providers of training, which included professional
bodies, employers, and pharmaceutical companies. These findings are supported by the
FIP CPD/CE global report from 2014 [5] that showed from 66 surveyed countries, that
59 (90.6%) used professional associations for pharmacist training. The report showed
83.1% of countries (54/66) used universities as providers, 55.4% (36/66) used employers,
30.8% (20/66) used regulators, and over half of the countries (34/66, 52.3%) used private
providers. If mandatory requirements are met, or opportunities are provided to keep up
to date, the provider should be the one best placed to deliver content, as previous studies
have identified that the facilitator is central to ensuring learning [2,26]; learning that is
relevant to practice is seen to support engagement. Previous literature has cited the benefits
of employer interventions/learning to support practical experiences. The studies show that
if a manager supports their team in learning, this is more likely to have an impact [27–29].
Schindel et al. [30] in 2019 showed that peer and manager support is needed in a time of
changing practice, and that CPD was successful if it encompassed learning in practice and
the workplace. Any CPD event is not truly successful, unless learning has been translated
into practice. O’Loan in 2019 [31], when surveying pharmacists in Northern Ireland, noted
that professional practice improved more when pharmacists had undertaken structured
CPD, and especially where it incorporated workplace learning activities. Feedback from
service users supported the demonstration of learning into practice. CPD is becoming more
evolved globally as the importance of ongoing education is recognised [32].
Belgium has taken the approach that one provider delivers all the required content
on multiple occasions to ensure consistency across the country. The CPPE model in GB is
in this manner. By having a centralised approach, this supports quality assurance of the
process, and of the providers, which is important to ensure consistent approaches. Ireland
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and USA utilise accreditation bodies to support assurance. Indeed, in their annual report
from 2017 [33], the IIOP stated that the system in place provided quality assurance and
ensured patient needs were being met with 95% engaging in the process.
Previous studies have highlighted that mandatory requirement for achieving profes-
sional development activity increases participation in events [34]. In this study, where
mandatory professional development activity requirements are in place, it is seen that proof
of attendance is required in multiple places for verification by the regulator. This places
the emphasis on the pharmacist to demonstrate they have participated in the learning.
However, it does not prove that application of learning into practice has been achieved. A
variety in experience of support for application of learning was seen in this study, with
some countries showing a culture of additional tools being provided in most cases. Ireland
has a system to ensure that pharmacists can demonstrate their learning in practice.
This study emphasises the findings of previous studies that there is no ‘one size fits
all’ approach for professional development activity, with advantages and disadvantages of
online and face-to-face learning events [35]. This echoes a previous study [36] by Driesen
et al. in 2007, that showed differing formats to be preferable for different audiences.
When looking at age preferences, previous research by Simonds [37] in 2014 showed
that with online learning, older students preferred to watch lectures, whereas younger
students preferred more interactive learning strategies. A previous study [38] identified
that those aged 36–45 had lower preference for face-to-face learning, possibly linking to
child-bearing age. The study identified that when considering pharmacists, even though
younger pharmacists were open to technology and online learning, they did not want it to
replace face-to-face contact completely [38], which was also found by Simonds [37].
Multiple previous studies have focused on format preferences, and the pros and cons of
each, and this study was no different. Face-to-face interactions allow participation and two-
way interaction, as well as the ability to ask questions, along with networking and sharing
experiences with peers. Whilst most face-to-face interactions at the time of this study were
in person, more face-to-face online sessions are now available. Online independent learning
with no instructor is a more flexible option that allows work at the participants own pace
and in their own time but limits the ability to engage with an instructor. Blended learning
supports the ability to have some face-to-face learning, along with some self-directed study.
There are challenges when introducing blended learning, as complex planning, time, and
resources are required, but there are multiple opportunities with this approach [39]. A
study from pharmacists in the Middle East showed that whilst pharmacists appreciated the
ability of online learning to be flexible, the challenges they faced included technology, time
management, and learner isolation [40]. This study highlighted that different topics were
more suitable for various formats, with the hands-on service-based learning better suiting
face-to-face learning and knowledge updates could be completed online. This has been
seen in undergraduate education, where grades improved when content was delivered
online followed by team-based classroom activities [41]. A study by Jeffries [42] in 2013
emphasised that e-learning can assist learners to keep up to date with new knowledge.
In this study, time has been cited as a barrier to CPD; both the time needed for
attendance and the time of the day. Pharmacists noted time as their biggest barrier to
participation in CPD [2]. Time for face-to-face events was the biggest barrier to attendance
in female doctors in a previous study [43]. Geography may affect the ability to join face-
to-face events, as seen in this study in Chile or Australia, echoed by a previous study in
rural Western Australia [44] that showed that journals were the most common source of
education, followed by reference books and the internet. Conversely, smaller countries such
as Malta, showed in this study that geography supported face-to-face provision. Location
of training has been identified as a barrier for attendance at learning events in multiple
previous studies [2,26]. In countries where CPD is not commonplace, lack of opportunities
or being unaware of the CPD concept could be a barrier, such as that in a 2018 study of
pharmacists in Ethiopia [45]. Nurses and paramedics saw more variety in learning times
than other professions, with events occurring during the day or during evenings, perhaps
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due to shift work to allow for participation. Daytime events were seen for safety reasons,
such as in Iraq.
Where evaluation forms are used for events, this study showed that similar questions
are asked, focusing on the event itself and the positives and negatives. Limited occasions
asked for intention of how the learning would be applied. Seeking understanding of intent
to apply learning would support pharmacists in CPD, to complete the cycle demonstrating
reflection of practice, which is an integral step of the CPD process, and is an opportunity
for the future.
In a systematic review of factors affecting global participation in pharmacy professional
activities, completed in 2020 [46], the four factors to increase participation were attitudes,
access to needs-based education, support, and policy, showing a collective and policy
driven approach is important.
The limitations of this study include that only one person from selected professions or
countries, apart from New Zealand, was interviewed so experiences will be varied, and
as the information provided by the respondents is self-reported opinions given regarding
preferences of learning would be personal and not necessarily representative of the whole
profession or country. Country variations may not be represented, e.g., in the USA, where
there are variations in requirements in different states. In addition, representatives from
professional bodies did not represent all professions, and regulators were not approached.
In addition, a purposive approach was taken to gain participants with known pharmacists
approached, which may have affected the range of countries sampled, and could have
potentially added bias to the results. As interviews took place in 2017 and 2018, information
may have changed since this study took place. Formats of learning have also changed after
the end of this study, due to the COVID-19 global pandemic.
However, the range of professions and countries represented showed the varied
practices that exist globally, demonstrating similarities and differences that can be built on
in future studies with larger cohorts, and that can give ideas for countries currently with
no regulations who may wish to implement changes.
5. Conclusions
It is seen that CPD is commonplace across healthcare practitioners in GB, similar to
pharmacists, and professions see the benefit of completing learning. For GB based pharma-
cists, CPD is now part of revalidation requirements, akin to doctors and nurses, showing
alignment of practice for the three largest healthcare professions in GB, supportive of a
multi-professional approach to patient care. From the sample interviewed in this study,
global revalidation for pharmacists was not mentioned explicitly. Globally for pharma-
cists, a variety of models of CPE/CE exist to ensure they are up-to-date, and even where
mandatory systems are not in place, there is a motivation from pharmacists to participate
in learning events. Participation and engagement are dependent on individual preferences
and needs. Learnings identified include flexibility in their approach to providing learning,
to allow registrants to participate how and when it is suitable for them, and summaries
and tools to support application of learning into practice were appreciated. There are still
inconsistencies globally about learning expectations, therefore countries and professions
should continue to work together to share experiences of processes and learning material
to support all pharmacists and other healthcare professionals with keeping up to date with
their practice in a way that supports the individual and assures the quality of CPD/CE.
Regulations should support this to ensure patient-based practice outcomes. Despite the
differences observed, this study showed that commitment to learning is similar in different
professions in GB and by pharmacists globally, with similar benefits and challenges.
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Appendix A. Interview Questions
1. How do you qualify to register as a healthcare professional?
2. What professional requirements surround the need to complete ongoing education
post registration in your profession/country?
3. How does your profession/country currently provide supplementary education post
registration?
4. What support, if any, is given to support education post registration?
5. When does learning traditionally take place?
6. Which providers are used for post registration education and training?
7. What do you think is the best model for post registration education and training and
why?
8. How is learning recorded and verified?
9. What tools or resources are currently used to help practitioners apply their learning
into practice?
10. Are there any tools that are not currently utilised that you feel would be of benefit to
support application of learning?
11. How does evaluation of learning events currently occur both at a training event and
afterwards?
12. Who carries out the evaluation?
13. Do you have any other comments that you think would be useful?
Appendix B. COREQ Checklist
Item No Guide(s)/Description On Page No






















What experience or training did the
researcher have?
RM–3 years of prior experience of
qualitative research
Methods-5
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What did the participants know about the
researcher? E.g., personal goals, reasons for
doing the research
Participants were made aware this was part
of a PhD study and emailed an information






What characteristics were reported about
the interviewer/facilitator? E.g., Bias,
assumptions, reasons and interests in the
research topic
PhD candidate and pharmacist
Methods-4






What methodological orientation was stated
to underpin the study? E.g., grounded














How were the participants approached?




How many participants were approached?




How many people refused to participate or
dropped out? Reasons?














Was anyone else present besides the
participants and researchers?





What are the important characteristic of the
sample? E.g., demographic data, date
Interviews were conducted between
February 2017 and October 2018
24 interviews–5 healthcare professionals in
GB, 5 professional body representatives in
GB, 14 pharmacists globally
Methods–4
Results-5
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Item No Guide(s)/Description On Page No
Data Collection
Interview Guide 17
Were questions, prompts, guides provided
by the authors? Was it pilot tested?
Semi-structured interviews were used.
Questions were provided by the authors.
Pilot testing was performed with three










Did the research use audio or visual
recording to collect the data?




Were field notes made during and/or/after
the interview or focus group?
No additional notes were made
Methods-4
Duration 21
What was the duraction of the interviews or
focus groups?
They lasted between 10–15 min
Methods-4
Data Saturation 22
Was data saturation discussed?






Were transcripts returned to particpants for
comments and/pr correction? No





How many data coders coded the data?
Transcripts were read by both members of





Did authors provide a description of the
coding tree?





Were themes identified in advance or
derived from the data?
Inductive content analysis was used
Methods-5
Software 27
What software, if applicable, was used to
manage the data?












Were participant quotations presented to
illustrate the themes/findings? Was each
quotation identified? E.g., participant
number
Comments were supported with direct
quotes from participants who were
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Was there consistency between the data










Is there a description of diverse cases or
discussion of minor themes? No
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